A moderate response to plasmapheresis in nephrogenic systemic fibrosis

Nephrogenic systemic fibrosis (NSF) is a recently identified idiopathic cutaneous fibrosing disorder that occurs in the setting of renal failure. The disease initially called nephrogenic fibrosing dermopathy is closely linked to exposure to gadolinium-based contrast media used during magnetic resona...

Full description

Bibliographic Details
Main Authors: Pelin Ustuner, Ozlem Karadag Kose, A. Tulin Gulec, Ozlem Ozen
Format: Article
Language:English
Published: MDPI AG 2011-11-01
Series:Clinics and Practice
Subjects:
Online Access:https://www.clinicsandpractice.org/index.php/cp/article/view/182
id doaj-1dc04ee7a1d442bd93c569198c31e15c
record_format Article
spelling doaj-1dc04ee7a1d442bd93c569198c31e15c2021-04-02T12:24:40ZengMDPI AGClinics and Practice2039-72752039-72832011-11-011410.4081/cp.2011.e124117A moderate response to plasmapheresis in nephrogenic systemic fibrosisPelin Ustuner0Ozlem Karadag Kose1A. Tulin Gulec2Ozlem Ozen3Department of Dermatology, Faculty of Medicine, Baskent University, AnkaraDepartment of Dermatology, Faculty of Medicine, Baskent University, AnkaraDepartment of Dermatology, Faculty of Medicine, Baskent University, AnkaraDepartment of Pathology, Faculty of Medicine, Baskent University, AnkaraNephrogenic systemic fibrosis (NSF) is a recently identified idiopathic cutaneous fibrosing disorder that occurs in the setting of renal failure. The disease initially called nephrogenic fibrosing dermopathy is closely linked to exposure to gadolinium-based contrast media used during magnetic resonance imaging in patients with renal insufficiency. Although little is known about the pathogenesis of this disease, the increased expression of transforming growth factor-beta has been demonstrated recently. Herein, we present a case of NSF was partially treated due to a moderate and temporary response to plasmapheresis with no recurrence for 6 months, but returned at the end of 6th month.https://www.clinicsandpractice.org/index.php/cp/article/view/182nephrogenic fibrosing dermopathyplasmapheresistransforming growth factors.
collection DOAJ
language English
format Article
sources DOAJ
author Pelin Ustuner
Ozlem Karadag Kose
A. Tulin Gulec
Ozlem Ozen
spellingShingle Pelin Ustuner
Ozlem Karadag Kose
A. Tulin Gulec
Ozlem Ozen
A moderate response to plasmapheresis in nephrogenic systemic fibrosis
Clinics and Practice
nephrogenic fibrosing dermopathy
plasmapheresis
transforming growth factors.
author_facet Pelin Ustuner
Ozlem Karadag Kose
A. Tulin Gulec
Ozlem Ozen
author_sort Pelin Ustuner
title A moderate response to plasmapheresis in nephrogenic systemic fibrosis
title_short A moderate response to plasmapheresis in nephrogenic systemic fibrosis
title_full A moderate response to plasmapheresis in nephrogenic systemic fibrosis
title_fullStr A moderate response to plasmapheresis in nephrogenic systemic fibrosis
title_full_unstemmed A moderate response to plasmapheresis in nephrogenic systemic fibrosis
title_sort moderate response to plasmapheresis in nephrogenic systemic fibrosis
publisher MDPI AG
series Clinics and Practice
issn 2039-7275
2039-7283
publishDate 2011-11-01
description Nephrogenic systemic fibrosis (NSF) is a recently identified idiopathic cutaneous fibrosing disorder that occurs in the setting of renal failure. The disease initially called nephrogenic fibrosing dermopathy is closely linked to exposure to gadolinium-based contrast media used during magnetic resonance imaging in patients with renal insufficiency. Although little is known about the pathogenesis of this disease, the increased expression of transforming growth factor-beta has been demonstrated recently. Herein, we present a case of NSF was partially treated due to a moderate and temporary response to plasmapheresis with no recurrence for 6 months, but returned at the end of 6th month.
topic nephrogenic fibrosing dermopathy
plasmapheresis
transforming growth factors.
url https://www.clinicsandpractice.org/index.php/cp/article/view/182
work_keys_str_mv AT pelinustuner amoderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT ozlemkaradagkose amoderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT atulingulec amoderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT ozlemozen amoderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT pelinustuner moderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT ozlemkaradagkose moderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT atulingulec moderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT ozlemozen moderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
_version_ 1721569073487151104